コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 nformation about other types of oestrogen or progestagen.
2 ments for hot flushes include oestrogens and progestagens.
3 8 (0.66-2.17) for the other third-generation progestagens.
4 in users of OCs containing second-generation progestagens.
5 only (1.30 [1.21-1.40], p<0.0001), oestrogen-progestagen (2.00 [1.88-2.12], p<0.0001), and tibolone (
7 easing hormone analogues, danazol, and depot progestagens are associated with a higher incidence of a
8 ins (also called gestagens, progestogens, or progestagens) are used today in assisting a range of med
9 nally, two secreted proteins, galectin-1 and progestagen-associated protein 14, known to have immunom
10 ffect is substantially greater for oestrogen-progestagen combinations than for other types of HRT.
13 a combined therapy of oestrogen with cyclic progestagen (eg. medroxyprogesterone acetate) had a rela
14 ptives (OCs) containing the third-generation progestagens gestodene or desogestrel than in users of O
15 d recruited healthy women.Combined oestrogen/progestagen HRT was used in three trials and oestrogen a
17 se combined therapy of oestrogen with cyclic progestagen on a long-term basis have an increased risk
18 impact of a regimen of oestrogen with cyclic progestagen on risk of endometrial cancer for postmenopa
20 aried little between specific oestrogens and progestagens or their doses; or between continuous and s
21 Among women with fewer than 10 days of added progestagen per month, the relative risk was 3.1 (1.7-5.
25 ast cancers, 15000 associated with oestrogen-progestagen; the extra deaths cannot yet be reliably est
27 cancer were generally greater for oestrogen-progestagen therapy than for oestrogen-only therapy, and
29 s from this study suggest that environmental progestagens will lead to defeminization at environmenta
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。